TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

28.10$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow AVLN
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – –
– -10.0% +600.0% +74.6%
– +107.7% +5.8% +133.9%
– – – –
– -100.0% – -15.4%
– – – -315.7%
– – – -100.0%
– – -83.5% +2,030.8%
– +571.0% +23.1% +329.8%
– – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?